Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Bifeprunox – Atypical Antipsychotic Drug

Drug (brand / generic)

Bifeprunox mesilate

Company / licensee

Solvay Pharmaceuticals / Lundbeck / Wyeth

Therapy class

Antipsychotic

Product description

Partial dopamine D2 agonist

Current indication

Treatment of schizophrenia

Market sector

CNS

Development status

Development ceased
Expand

Go Top